Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-038044
Filing Date
2025-03-12
Accepted
2025-03-12 16:55:31
Documents
88
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scyx-20241231.htm   iXBRL 10-K 3041557
2 EX-19.1 scyx-ex19_1.htm EX-19.1 57730
3 EX-23.1 scyx-ex23_1.htm EX-23.1 3997
4 EX-31.1 scyx-ex31_1.htm EX-31.1 14784
5 EX-31.2 scyx-ex31_2.htm EX-31.2 14765
6 EX-32.1 scyx-ex32_1.htm EX-32.1 12520
  Complete submission text file 0000950170-25-038044.txt   13416451

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scyx-20241231.xsd EX-101.SCH 1785047
90 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20241231_htm.xml XML 2654107
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36365 | Film No.: 25732446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)